EQIPD Stakeholders
The stakeholder group contributed to the development of the EQIPD Quality System and is the important voice of the research community for the Guarantors of EQIPD
EQIPD actively involves stakeholders – from leading research organizations but also funders and publishers – in order to collect and understand needs and expectations, current best practices and challenges.
Alexander Dityatev, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
Alicia Faruzzi Brantley, Scripps FL
Andreas Scherer, Institute for Molecular Medicine Finland (FIMM)
Anne-Charlotte Fauvel, ACXIS
Anne-Laure Bonnefont, Institut national de la santé et de la recherche médicale (INSERM U1183
Arnoud Herremans, Y47
Ben Fitzpatrick, Tempest Technologies
Bernard Lerer, Hadassah – Hebrew University Medical Center
Bruce O’Hara, University of Kentucky (UKY)
Chantelle Ferland-Beckham, Cohen Veterans Bioscience
Christina Dalla, National and Kapodistrian University of Athens (NKUA)
Claudia Pitzer University of Heidelberg (UHEI)
David McKinzie, Indiana University
Elsa Pioli, Motac Neuroscience Ltd (Motac)
Eric M. Prager, Wiley
Ernesto Prado Montes de Oca, Personalized Medicine National Laboratory (LAMPER)
Frank Hughes, Tietronix Software
Frank Thadewaldt, Enso Software GmbH
Gerald M. Herrera, Med Associates Inc.
Gernot Riedel, University of Aberdeen
Hanno Würbel, University of Bern
Igor Branchi, Instituto Superiore di Sanità
Ioannis Sotiropoulos, University of Minho
Irina V. Belozertseva, Pavlov Med Uni
Jan Vollert, Imperial College London
Janko Samardzic, University of Belgrade
Jean Claude Dorego, Université de Rouen Normandie (UNIV ROUEN)
Jean Luc Dorego, Université de Rouen Normandie (UNIV ROUEN)
John Kroehle, Jr., Data Sciences International Inc.
Jonathan Ward, ETH Zuerich
Jos Prickaerts, Univeristy Maastricht
Judith Homberg,Radboud Universität, Nijmegen Medical Centre (RUMC)
Julian Selley, University of Manchester
Karine Cambon, Institut François Jacob/ MIRCen
Ken Drake, Seralogix
Lawrence Moon, King’s College London
Leonardo Restivo, Lausanne University
Lior Bikovski, Tel Aviv University (TAU)
Lucianne Groenink, Utrecht University
Magali Dumont, ICM-Hôpital Pitié-Salpêtrière
Magali Haas, Cohen Veterans Bioscience
Marc Le Bert, FC3R – France Centre 3Rs
Marcus Meinhardt, CIMH
Marianne Kordel, Deutsches Zentrum für Luft- und Raumfahrt (DLR)
Martien Kas, University of Groningen
Martin de Kort, European Infrastructure for Translational Medicine (EATRIS)
Markus Kreuz, Fraunhofer Institute for Cell Therapy and Immunology IZI
Matt McLoughlin, Scientist.com
Michael Curtis, King’s College London (KCL)
Michael Schunn, Institute of Science and Technology
Michael Tsoory, Weizmann Institute of Science (Weizmann)
Natasja de Bruin & Martine Hoffmann, Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie (Frauenhofer IME)
Nuno Moreno (Instituto Gulbenkian de Ciencia)
Olivier Blin, Pharmacologie clinique – Hôpital de la Timone (La Timone)
Osvalds Pugovics, The Latvian Institute of Organic Synthesis
Paul Moser, CERBASCIENCE EIRL
Piotr Popik, Institute of Pharmacology Polish Academy of Sciences (IF-PAN)
Raafat Farés, Etisense SAS
Rainer Spanagel, CIMH
Ronan O’cualain, University of Manchester
Sabine Hölter, Helmholtz Zentrum München, Institute of Developmental Genetics (IDG)
Sandrine Bongiovanni, Novartis
Sara Wells, Medical Research Council (MRC UK)
Simon Loiodice, Biotrial
Stacey Rizzo, The Jackson Laboratory (JAX)
Sylvia Badurek, Vienna Biocenter Core Facilities GmbH (VBCF)
Sylvie Ramboz, PsychoGenics Inc.
Thomas van Groen, The University of Alabama at Birmingham (UAB)
Todd Sherer, The Michael J. Fox Foundation
Valérie Bertaina-Anglade, Biotrial
Valerie Gailus-Durner, Helmholtz Zentrum München, Institute of Experimental Genetics (IEG)
Vootele Voikar, Helsinki University
* Please note: only stakeholders who gave consent to be publicly mentioned are listed here. *
Become a Stakeholder
Join us today
If you would also like to contribute and get involved in our activities, you can sign up for our bimonthly newsletter and contact us directly to become a stakeholder.